Loading evidence-driven research…
Herb Profile
Botanical profile with evidence, safety, and practical fit.
Evidence level
Strong Human Evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Low caution
Best for
Sleep, Stress, Stress resilience
Avoid / review if
Hyperthyroidism, Sedatives
Evidence Engine proof of concept
A claim-level view for one practical question: does the evidence justify considering ashwagandha for perceived stress?
Bottom line
Several short randomized placebo-controlled trials in adults with self-reported stress report improvements on perceived-stress or anxiety scales, often alongside cortisol changes.
The signal is not strong enough for hype: studies are small, short, often use different branded extracts, and at least one relevant trial in stressed, fatigued adults did not reduce perceived stress versus placebo.
This claim matters most to generally healthy adults comparing non-prescription options for everyday stress, especially when stress feels tense, sleep-adjacent, or rumination-heavy.
Decision snapshot
The evidence supports a cautious trial only for people whose safety context fits. It does not support treating ashwagandha as risk-free or as a replacement for care.
✓ Consider with caution
Best-supported action for a generally healthy adult after reviewing pregnancy, thyroid, liver, autoimmune, sedative, blood-pressure, blood-sugar, and medication concerns.
Consider
Too casual for this claim because the benefit signal is short-term and the safety profile has real caveats.
Experimental
The human evidence is stronger than purely experimental, but extract-specific uncertainty remains.
Avoid in context
Applies when pregnant or breastfeeding, with liver disease history, thyroid instability, hormone-sensitive prostate cancer, or relevant medication risk unless a clinician says otherwise.
Not enough evidence
Not the right overall label: multiple human trials exist, but they are not definitive.
Evidence breakdown
High
The core signal comes from randomized placebo-controlled trials in human adults reporting stress, not only from animal or mechanistic data.
Moderate-high
Most supportive studies measure perceived stress or anxiety directly, but preparations, doses, outcome scales, and stress definitions differ.
Moderate
Placebo control and blinding help, while small samples, short durations, branded extracts, and limited independent replication keep confidence below strong.
Moderate
Most trials point toward benefit, but not every relevant trial improves perceived stress; the disagreement changes the decision from simple “consider” to “consider with caution.”
Moderate
Potentially useful for subjective stress over 4–12 weeks, but it is not acute rescue, not a substitute for care, and not proven for long-term stress management.
Supporting evidence
| Year | Type | Population | Sample | Duration | Result | Relevance |
|---|---|---|---|---|---|---|
| 2012 | Randomized, double-blind, placebo-controlled trial | Adults with chronic self-reported stress | 64 | 60 days | High-concentration root extract improved perceived stress and related well-being measures versus placebo. | Directly supports the claim, but it is small and extract-specific. |
| 2019 | Randomized, double-blind, placebo-controlled three-arm trial | Stressed healthy adults with elevated perceived stress scores | 60 | 8 weeks | Ashwagandha groups reported greater stress reduction than placebo; pharmacologic stress markers also moved favorably. | Directly relevant to generally healthy adults, with dose comparison, but still small. |
| 2021 | Randomized, double-blind, placebo-controlled trial | Healthy stressed adults | 130 | 90 days | Sustained-release root extract improved validated stress and sleep measures and lowered cortisol versus placebo. | A larger short-term trial that supports the stress claim, though it uses one standardized extract. |
| 2022 | Randomized, placebo-controlled trial | Adults reporting perceived stress | 60 | 30 days | Root-and-leaf extract groups reported improvements in stress, anxiety, mood, and cravings; one dose lowered salivary cortisol. | Useful supportive signal, but the 30-day window and root/leaf extract limit generalization. |
Contradictory evidence
A 2023 trial in adults with high stress and fatigue found fatigue improvement but not a clear perceived-stress reduction versus placebo.
Population, baseline fatigue, extract chemistry, dose, study duration, and outcome sensitivity can all change whether perceived stress moves.
This keeps the label at Moderate and changes the practical state to “consider with caution,” not “strongly recommended.”
Safety before sourcing
What we still do not know
Source trail
Next decisions
Generally well tolerated for most users.
Ashwagandha Withania Somnifera has a strong human evidence evidence level. It is categorized as preliminary with a mechanism-heavy evidence style.
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping. Sourcing availability is evaluated separately from safety and clinical efficacy scores.
Affiliate Disclosure: Clicking verification or shopping links may earn this site a commission at no additional cost to you. Sourcing links are selected strictly based on quality criteria and availability, never based on commission tiers. Safety warnings and evidence ratings remain independent of sourcing.